835621-07-3 Regorafenib hydrochloride seller in China Regorafenib hydrochloride factory in China
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Regorafenib (Hydrochloride) Basic information |
Product Name: | Regorafenib (Hydrochloride) |
Synonyms: | Regorafenib (Hydrochloride);BAY73-4506 hydrochloride;4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrochloride;Regafenib HCL |
CAS: | <a keyword="835621-07-3" "="" style="margin: 0px auto; padding: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; border: 0px; color: rgb(0, 51, 153); outline: none;">835621-07-3 |
MF: | C21H16Cl2F4N4O3 |
MW: | 519.2763528 |
EINECS: | |
Product Categories: | |
Mol File: | 835621-07-3.mol |
Regorafenib (Hydrochloride) Chemical Properties |
Safety Information |
Regorafenib (Hydrochloride) Usage And Synthesis |
Usage |
BAY 73-4506 (Regorafenib) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View